Disseminated gonococcal infection in a patient with paroxysmal nocturnal hemoglobinuria having received ravulizumab and meningococcal vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disseminated gonococcal infection in a patient with paroxysmal nocturnal hemoglobinuria having received ravulizumab and meningococcal vaccine

Published:2020-08 Issue:4 Volume:53 Page:660-662
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Yu Zhi-Ye,Tsai Ming-Jui,Lin Yu-Jen,Liu Wang-Da,Chou Sheng-Chieh,Hung Chien-Ching

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference6 articles.

1. Gonococcal septic shock associated with eculizumab treatment;Gleesing;Pediatr Infect Dis J,2012

2. Disseminated gonococcal infection and eculizumab--a "high risk" connection?;Hublikar;Sex Transm Dis,2014

3. Risks of novel therapeutics: gonococcemia in an immune-suppressed patient receiving eculizumab;Khandelwal;CMAJ (Can Med Assoc J),2017

4. Disseminated gonococcal infections in patients receiving eculizumab: a case series;Crew;Clin Infect Dis,2019

5. Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis;Socié;Br J Haematol,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-capsulated Neisseria meningitidis sepsis in a paroxysmal nocturnal hemoglobinuria patient treated with ravulizumab: case report and review of the literature;Frontiers in Immunology;2023-10-02

2. Uncomplementary;Clinical Infectious Diseases;2023-09-15

3. Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2;Blood Reviews;2023-07

4. Detection of Neisseria meningitidis in a patient receiving ravulizumab by the FilmArray® Meningitis/Encephalitis panel- A case report.;Journal of Infection;2021-06

5. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway;Frontiers in Immunology;2020-12-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3